At a glance
ClinicalIndex Comparison RecordPhase 3Active· 216 enrolled
Drug / intervention
Best Practice +3 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Mepitel Film for the Reduction of Radiation Dermatitis in Breast Cancer Patients Undergoing Post-Mastectomy Radiation Therapy: A Randomized Phase III Clinical Trial
In Brief
A Phase 3 clinical trial evaluating Best Practice, Wound Dressing Material, and 2 other interventions for Breast Carcinoma and Mastectomy Patient. Active but no longer recruiting, targeting 216 participants across 49 sites.
Detailed Summary
This phase III trial studies how well Mepitel Film works in reducing radiation dermatitis (redness and peeling) in patients with breast cancer during radiation therapy after a mastectomy. Mepitel Film may reduce the severity of skin redness and peeling in the area of radiation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Carcinoma, Mastectomy Patient
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
Phase 3Active
20222023202420252026202720282029
First PostedAug 2021
Enrollment StartJul 2022
Primary CompletionMay 2024
TodayJul 2026
Study CompletionFeb 2029
First PostedAug 4, 2021
Enrollment StartJul 26, 2022
Primary CompletionMay 29, 2024
Study CompletionFeb 15, 2029
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 4.9 years ago
Interventions
Best Practiceother
Receive standard of care
Wound Dressing Materialdevice
Apply Mepitel Film
Quality-of-Life Assessmentother
Ancillary studies
Questionnaire Administrationother
Ancillary studies